Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Ependymoma × picropodophyllin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Oligodendroglioma 1 Gliosarcoma 1 Glioblastoma 1 Ependymoma 1 Astrocytoma 1

Interventions

Temozolomide 3 Nivolumab 2 veliparib 1 picropodophyllin 1 lutetium Lu 177 dotatate 1 dostarlimab 1 dinutuximab 1 bempegaldesleukin 1 abemaciclib 1 Radiotherapy 1 Proton Therapy 1 Irinotecan 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Ethanol 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01721577 2023-05-22

AXL1717

Rush University Medical Center

Phase 1/2 Terminated

10 enrolled 8 charts

Astrocytoma, Ependymoma, Glioblastoma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡